Cleopatra Hospitals Group (CHG), an Egypt-based healthcare investment platform, is planning to  make an investment of E£2bn ($64.62m) over a period of next 18 months for the Sky Hospital project in East Cairo. 

According to a press release shared by Zawya, this investment is part of the company’s profit expectations strategy before interest, taxes, and depreciation for the forthcoming two years.  

As part of the planned investment, CHG will primarily focus on the first and second phases of the Sky Hospital project, expansion of outpatient clinic centres and Cleopatra October facilities in West Cairo. 

The company has clarified that this investment amount excludes any potential expansions outside Cairo.  

CHG’s capital expenditures will be fully financed from bank facilities and internal sources.  

During the previous year, CHG anticipated a 35% annual growth in its revenues. 

In the last quarter of 2023, the hospital also anticipated a 44% revenue growth annually. This was supported by a rise in the number of cases the company served, improved operational efficiency, and the diversification of healthcare services offered.  

The hospital's profits surged by 29% during the first nine months of the previous year, totalling E£344.9m, compared to E£267.1m during the same period in 2022. 

CHG operates six hospitals in the country, alongside two polyclinics and one IVF centre in Egypt, catering to a diverse range of patient needs and preferences. 

It offers comprehensive diagnostic, medical, and surgical facilities in both inpatient and outpatient units at every facility. 

The hospital also has various centres of excellence that provide quality care for specialties such as urology, cardiology, neurology, orthopaedics, among others.  

In May 2021, CHG announced filing of regulatory approval on a mandatory tender offer to acquire all the outstanding shares of Alexandria Medical Services.